A total of 4,179 boxes of Tydemy brand birth control pills have been recalled, which amounts to about 350,000 tablets that might be less effective at stopping pregnancy.
, after testing by drugmaker Lupin Pharmaceuticals found that two lots they made of the tablets might have lower effectiveness.
People who are currently taking recalled lots of the drugs are urged to continue taking their pills but immediately seek out an alternative from their doctor. Drugmakers routinely do what's called "stability" testing to ensure that medications they produce are still good to use out to their expiration dates.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Thousands of Tydemy birth control pills recalled, may be ineffective, FDA warnsA drugmaker recalled thousands of birth control pills after testing found they might have lower effectiveness.
Lire la suite »
FDA, DEA call on drugmakers to boost manufacturing amid ongoing shortage of prescription stimulants | CNNAmid an ongoing shortage of prescription stimulants in the US, federal agencies are calling on drugmakers to boost manufacturing and on health care providers to closely monitor prescribing practices.
Lire la suite »
FDA, DEA Blame Demand, Drug Makers for ADHD Med ShortageIn a letter to the public the FDA and the DEA contend that unprecedented demand, potential overprescribing, and underproduction are the primary reasons for the national shortage of stimulants to treat ADHD.
Lire la suite »
Two arrested after Chandler PD finds thousands of fentanyl pills, cash, firearmsLast Wednesday, detectives with the Chandler Police Department Narcotics Unit arrested a man during a drug investigation. MORE ⬇️
Lire la suite »
Two arrested after police find thousands of fentanyl pills, cash, firearmsTwo people were arrested in connection to an illegal fentanyl bust of 51,000 fentanyl pills,10 firearms and $31,760 in cash.
Lire la suite »
Morning Bid: Testing the 'Goldilocks' view of the global economyA look at the day ahead in European and global markets from Kevin Buckland.
Lire la suite »